Analysis of the same database for DDR1 expression vs. NRAS mutational status showed DDR1 to be slightly downregulated in all NRAS-mutated cancers (effect size −0.26, p = 0.00053) and with a similar tendency (effect size −0.29, p = 0.065, Figure 1C). The gene discussed is DDR1; the disease is cancer.